125 related articles for article (PubMed ID: 20692737)
1. Roscovitine-based CDK inhibitors acting as N-donor ligands in the platinum(II) oxalato complexes: preparation, characterization and in vitro cytotoxicity.
Trávnícek Z; Starha P; Popa I; Vrzal R; Dvorák Z
Eur J Med Chem; 2010 Oct; 45(10):4609-14. PubMed ID: 20692737
[TBL] [Abstract][Full Text] [Related]
2. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.
Starha P; Trávnícek Z; Popa I
J Inorg Biochem; 2010 Jun; 104(6):639-47. PubMed ID: 20304500
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.
Vrzal R; Starha P; Dvorák Z; Trávnícek Z
J Inorg Biochem; 2010 Oct; 104(10):1130-2. PubMed ID: 20673688
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and in vitro cytotoxicity of the first palladium(II) oxalato complexes involving adenine-based ligands.
Starha P; Trávnícek Z; Popa I
J Inorg Biochem; 2009 Jul; 103(7):978-88. PubMed ID: 19457557
[TBL] [Abstract][Full Text] [Related]
5. Platinum(II)-oxalato complexes of seliciclib (CYC202) derivatives show different cellular effects and lesser adverse effects in mouse lymphoma model than cisplatin.
Vančo J; Štarha P; Hošek J; Chalupová M; Suchý P; Trávníček Z
J Biol Inorg Chem; 2020 Feb; 25(1):67-73. PubMed ID: 31673793
[TBL] [Abstract][Full Text] [Related]
6. Platinum(II) oxalato complexes involving adenosine-based N-donor ligands: synthesis, characterization and cytotoxicity evaluation.
Starha P; Popa I; Trávníček Z
Molecules; 2014 Mar; 19(3):3832-47. PubMed ID: 24662093
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of in vitro cytotoxicity of 6-benzylaminopurine carboplatin derivatives against human cancer cell lines and primary human hepatocytes.
Dvořák Z; Starha P; Trávníček Z
Toxicol In Vitro; 2011 Apr; 25(3):652-6. PubMed ID: 21232594
[TBL] [Abstract][Full Text] [Related]
8. Zinc(II) complexes with potent cyclin-dependent kinase inhibitors derived from 6-benzylaminopurine: synthesis, characterization, X-ray structures and biological activity.
Trávnícek Z; Krystof V; Sipl M
J Inorg Biochem; 2006 Feb; 100(2):214-25. PubMed ID: 16386795
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and in vitro antitumor activity of platinum(II) oxalato complexes involving 7-azaindole derivatives as coligands.
Štarha P; Trávníček Z; Popa I; Dvořák Z
Molecules; 2014 Jul; 19(8):10832-44. PubMed ID: 25068781
[TBL] [Abstract][Full Text] [Related]
10. Mixed ligand complexes of platinum(II) and palladium(II) with cytokinin-derived compounds Bohemine and Olomoucine: X-ray structure of [Pt(BohH+-N7)Cl(3)].9/5H2O [Boh=6-(benzylamino)-2-[(3-(hydroxypropyl)-amino]-9-isopropylpurine, Bohemine].
Trávnícek Z; Malon M; Zatloukal M; Dolezal K; Strnad M; Marek J
J Inorg Biochem; 2003 Apr; 94(4):307-16. PubMed ID: 12667701
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, spectral study and cytotoxicity of platinum(II) complexes with 2,9-disubstituted-6-benzylaminopurines.
Malon M; Trávnícek Z; Marek R; Strnad M
J Inorg Biochem; 2005 Nov; 99(11):2127-38. PubMed ID: 16143400
[TBL] [Abstract][Full Text] [Related]
12. N6-benzyladenosine derivatives as novel N-donor ligands of platinum(II) dichlorido complexes.
Starha P; Popa I; Trávníček Z; Vančo J
Molecules; 2013 Jun; 18(6):6990-7003. PubMed ID: 23771060
[TBL] [Abstract][Full Text] [Related]
13. One-dimensional oxalato-bridged Cu(II), Co(II), and Zn(II) complexes with purine and adenine as terminal ligands.
García-Terán JP; Castillo O; Luque A; García-Couceiro U; Román P; Lloret F
Inorg Chem; 2004 Sep; 43(18):5761-70. PubMed ID: 15332829
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
15. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of new Pt(II) and Pd(II) complexes with 2-quinolinecarboxaldehyde selenosemicarbazone: cytotoxic activity evaluation of Cd(II), Zn(II), Ni(II), Pt(II) and Pd(II) complexes with heteroaromatic selenosemicarbazones.
Gligorijević N; Todorović T; Radulović S; Sladić D; Filipović N; Godevac D; Jeremić D; Andelković K
Eur J Med Chem; 2009 Apr; 44(4):1623-9. PubMed ID: 18789831
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives.
Trávnícek Z; Szucová L; Popa I
J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304
[TBL] [Abstract][Full Text] [Related]
18. Platinum(ii) complexes showing high cytotoxicity toward A2780 ovarian carcinoma cells.
Choroba K; Machura B; Raposo LR; Małecki JG; Kula S; Pająk M; Erfurt K; Maroń AM; Fernandes AR
Dalton Trans; 2019 Sep; 48(34):13081-13093. PubMed ID: 31411239
[TBL] [Abstract][Full Text] [Related]
19. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
[TBL] [Abstract][Full Text] [Related]
20. The synthesis, characterisation and cytotoxicity of bisintercalating (2,2':6',2''-terpyridine)platinum(II) complexes.
Harper BW; Aldrich-Wright JR
Dalton Trans; 2015 Jan; 44(1):87-96. PubMed ID: 25407567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
